We are delighted to be attending, sponsoring and presenting at the RAPS Euro Convergence from 5-8 April in Lisbon. Purdie Pascoe’s Post Market Survey experts Marcus Torr (Head of Post Market Surveys) Ellie Baker (Commercial Director) Alice Robertson (Research Manager) and Ruby Pogson Jones (Senior Research Executive ) are exhibiting on booth 31.
The 2026 MedTech Clinical Network Conference, hosted by TT Life Sciences in Brussels, brought together clinical leaders from across Europe at a pivotal time for the MedTech sector. Rather than simply revisiting regulatory updates, this year’s discussions focused on a broader challenge: how organisations can navigate uncertainty, strengthen clinical strategy, and generate evidence that delivers both regulatory assurance and commercial value.
Real-World Evidence (RWE) is playing an increasingly important role in global MedTech regulatory decision-making, supporting evidence generation across the product lifecycle, from pre-market submissions to post-market surveillance. Watch this webcast which features industry experts to understand how MedTech manufacturers can build effective, compliant RWE strategies.
He has extensive knowledge in the specific requirements surrounding PMCF surveys, having overseen over 500 surveys for several of the leading global Medical Device manufacturers across a variety device types. These surveys have been approved by several of the leading Notified Bodies and consist of both end user general surveys and high-quality patient specific surveys.
